THE IMPORTANCE OF FODMAP-RESTRICTIVE DIET IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME

Abstract

Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal condition characterized by abdominal pain, distension, gas, and changes in intestinal transit, significantly impacting the quality of life of patients. Among the available therapeutic approaches, the low-FODMAP diet has stood out as an effective strategy for managing IBS symptoms, reducing intestinal fermentation and promoting greater control of digestive discomfort. This study aims to analyze the importance of a FODMAP-restrictive diet in the treatment of IBS, considering its clinical efficacy, nutritional impacts, and the need for professional follow-up to avoid nutritional deficits. The results indicate that approximately 70% of patients who adhere to the low-FODMAP diet show significant improvement in gastrointestinal symptoms, in addition to psychological and social benefits, making this approach one of the most recommended in clinical practice. However, the need for individualization of the diet and adequate nutritional monitoring to ensure safety and long-term sustainability is emphasized. It is concluded that the low-FODMAP diet represents a significant advance in the treatment of IBS, providing substantial improvements in the quality of life of patients and reducing dependence on drug treatments.